Invention Grant
- Patent Title: Biomarkers for diagnosing alzheimer's disease
- Patent Title (中): 用于诊断阿尔茨海默病的生物标志物
-
Application No.: US13099110Application Date: 2011-05-02
-
Publication No.: US08772042B2Publication Date: 2014-07-08
- Inventor: Özkan Yalkinoglu , Gerhard König , Denis Francois Hochstrasser , Jean-Charles Sanchez , Odile Carrette
- Applicant: Özkan Yalkinoglu , Gerhard König , Denis Francois Hochstrasser , Jean-Charles Sanchez , Odile Carrette
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Agency: Edwards Wildman Palmer LLP
- Agent Ralph A. Loren; Edmund J. Koundakjian
- Priority: EP02018283 20020823; EP02026643 20021129
- Main IPC: G01N33/00
- IPC: G01N33/00
Abstract:
A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific peptide markers, e.g., using mass spectrometric analysis.
Public/Granted literature
- US20120016205A1 BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE Public/Granted day:2012-01-19
Information query
